Advertisement

Topics

Latest "Nuvelo, Inc." News Stories

19:39 EST 18th November 2018 | BioPortfolio

Here are the most relevant search results for "Nuvelo, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Nuvelo, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Nuvelo, Inc. for you to read. Along with our medical data and news we also list Nuvelo, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Nuvelo, Inc. Companies for you to search.

Showing "Nuvelo" News Articles, all 4

Wednesday 14th November 2018

ARCA biopharma Inc ABIO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryARCA Biopharma Inc ARCA, formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique betablocker that is being developed for the treatment and prevention of atrial fibrillation in patients with heart failure and reduced left ventricular eject...


Monday 13th August 2018

ARCA biopharma Inc ABIO Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12042018] Prices from USD $250

SummaryARCA Biopharma Inc ARCA, formerly Nuvelo Inc is a drug development company that develops genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique betablocker that is being developed for the prevention of atrial fibrillation in patients with heart failure and reduced left ventr...

Tuesday 31st July 2018

ARCA biopharma Inc ABIO Medical Equipment Deals and Alliances Profile [Report Updated: 11052018] Prices from USD $250

SummaryARCA Biopharma Inc ARCA, formerly Nuvelo Inc is a drug development company that develops genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique betablocker that is being developed for the prevention of atrial fibrillation in patients with heart failure and reduced left ventr...


Thursday 26th July 2018

ARCA biopharma Inc ABIO Medical Equipment Deals and Alliances Profile [Report Updated: 12072018] Prices from USD $250

SummaryARCA Biopharma Inc ARCA, formerly Nuvelo Inc is a developer of genetically targeted therapies for cardiovascular diseases. The company's product candidate include Gencaro, a mild vasodilator and investigational pharmacologically unique betablocker that is being developed for the treatment and prevention of atrial fibrillation in patients with heart failure and reduced left ventricular eject...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks